DE602006019953D1 - Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90 - Google Patents

Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90

Info

Publication number
DE602006019953D1
DE602006019953D1 DE602006019953T DE602006019953T DE602006019953D1 DE 602006019953 D1 DE602006019953 D1 DE 602006019953D1 DE 602006019953 T DE602006019953 T DE 602006019953T DE 602006019953 T DE602006019953 T DE 602006019953T DE 602006019953 D1 DE602006019953 D1 DE 602006019953D1
Authority
DE
Germany
Prior art keywords
chapterone
inhibitors
compositions
activity
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006019953T
Other languages
English (en)
Inventor
Patrick Mailliet
Luc Bertin
Didier Benard
Chantal Carrez
Francois Vallee
Eric Bacque
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE602006019953D1 publication Critical patent/DE602006019953D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602006019953T 2005-04-08 2006-04-05 Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90 Active DE602006019953D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503511A FR2884252B1 (fr) 2005-04-08 2005-04-08 Nouveaux derives d'isoindoles, compositions les contenant, leur preparation et leurs utilisations pharmaceutiques notamment en tant qu'inhibiteurs d'activites de la proteine chaperone hsp90
PCT/FR2006/000750 WO2006108948A2 (fr) 2005-04-08 2006-04-05 Nouveaux derives d'isoindoles, compositions les contenant, leur preparation et leurs utilisations pharmaceutiques notamment en tant qu'inhibiteurs d'activites de la proteine chaperone hsp90

Publications (1)

Publication Number Publication Date
DE602006019953D1 true DE602006019953D1 (de) 2011-03-17

Family

ID=35539484

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006019953T Active DE602006019953D1 (de) 2005-04-08 2006-04-05 Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90

Country Status (17)

Country Link
US (1) US8034939B2 (de)
EP (1) EP1869042B1 (de)
JP (1) JP5124443B2 (de)
KR (1) KR20080002809A (de)
CN (1) CN101287733A (de)
AR (1) AR053206A1 (de)
AT (1) ATE497501T1 (de)
AU (1) AU2006234396A1 (de)
BR (1) BRPI0609734A2 (de)
CA (1) CA2603634A1 (de)
DE (1) DE602006019953D1 (de)
FR (1) FR2884252B1 (de)
IL (1) IL186050A0 (de)
RU (1) RU2375361C2 (de)
TW (1) TW200718700A (de)
UY (1) UY29468A1 (de)
WO (1) WO2006108948A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885904B1 (fr) * 2005-05-19 2007-07-06 Aventis Pharma Sa Nouveaux derives du fluorene, compositions les contenant et utilisation
WO2008045529A1 (en) * 2006-10-12 2008-04-17 Serenex, Inc. Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases
FR2932484B1 (fr) 2008-06-16 2010-06-18 Sanofi Aventis Nouveaux derives de pyrroloindole inhibiteurs d'hsp90, compositions les contenant et utilisation
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
PL2560645T3 (pl) * 2010-04-21 2017-01-31 Syntarga B.V. Koniugaty analogów CC-1065 i łączników dwufunkcyjnych
UY36629A (es) 2015-04-17 2016-11-30 Abbvie Inc Indazolonas como moduladores de la señalización de tnf
EP3288939A1 (de) 2015-04-17 2018-03-07 AbbVie Inc. Tricyclische modulatoren des tnf-signalwegs
WO2016168638A1 (en) 2015-04-17 2016-10-20 Abbvie Inc. Indazolones as modulators of tnf signaling
KR101925395B1 (ko) 2016-01-29 2019-02-27 계명대학교 산학협력단 Ｈｓｐ９０ 억제 활성을 갖는 신규 디히드록시페닐계 화합물 또는 이의 약제학적으로 허용가능한 염 및 이의 의학적 용도
US10131663B2 (en) 2016-10-24 2018-11-20 Astrazeneca Ab Chemical compounds
CA3050337A1 (en) 2017-01-30 2018-08-02 Astrazeneca Ab Estrogen receptor modulators
KR20190014474A (ko) 2017-08-02 2019-02-12 계명대학교 산학협력단 Ｈｓｐ９０ 억제 활성을 갖는 디히드록시페닐계 입체이성질체 및 이의 의학적 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001106673A (ja) * 1999-07-26 2001-04-17 Banyu Pharmaceut Co Ltd ビアリールウレア誘導体
GB0228417D0 (en) 2002-12-05 2003-01-08 Cancer Rec Tech Ltd Pyrazole compounds
GB0229618D0 (en) * 2002-12-19 2003-01-22 Cancer Rec Tech Ltd Pyrazole compounds
WO2004072081A1 (en) * 2003-02-10 2004-08-26 Cellular Genomics, Inc. Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
CA2515726C (en) 2003-02-11 2012-07-10 Vernalis (Cambridge) Limited Isoxazole compounds
GB0309637D0 (en) * 2003-04-28 2003-06-04 Cancer Rec Tech Ltd Pyrazole compounds
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
CN100567242C (zh) 2003-06-27 2009-12-09 协和发酵麒麟株式会社 Hsp90家族蛋白质阻断剂

Also Published As

Publication number Publication date
ATE497501T1 (de) 2011-02-15
BRPI0609734A2 (pt) 2010-04-27
AU2006234396A1 (en) 2006-10-19
UY29468A1 (es) 2006-11-30
WO2006108948A3 (fr) 2007-10-11
RU2375361C2 (ru) 2009-12-10
WO2006108948A2 (fr) 2006-10-19
US8034939B2 (en) 2011-10-11
RU2007141398A (ru) 2009-05-20
EP1869042A2 (de) 2007-12-26
FR2884252A1 (fr) 2006-10-13
CA2603634A1 (fr) 2006-10-19
TW200718700A (en) 2007-05-16
JP5124443B2 (ja) 2013-01-23
CN101287733A (zh) 2008-10-15
IL186050A0 (en) 2008-06-05
FR2884252B1 (fr) 2007-05-18
US20080119507A1 (en) 2008-05-22
JP2008534660A (ja) 2008-08-28
KR20080002809A (ko) 2008-01-04
EP1869042B1 (de) 2011-02-02
AR053206A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
DE602006019953D1 (de) Neue isoindolderivate, zusammensetzungen damit, ihre herstellung und pharmazeutische verwendung, insbesondere als hemmer der aktivität des chaperonproteins hsp90
DE602005026395D1 (de) Neue zyklische harnstoffderivate, deren herstellung und pharmazeutische verwendung damit als kinase-inhibitoren
DE50311318D1 (de) Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
DE502005006424D1 (de) Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DE50312747D1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE538125T1 (de) Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren
BRPI0508263B8 (pt) derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina
ATE553096T1 (de) Pyridazinderivate und ihre verwendung als therapeutische wirkstoffe
DE602006013878D1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
ATE430145T1 (de) 3-ä(2-ä 4-(hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü -propionsäure- ethylester -methansulfonat und dessen verwendung als arzneimittel
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
DE502005002105D1 (de) 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln
ATE381333T1 (de) Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
DE602005006815D1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
DE602007005487D1 (de) Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung
DE602005019743D1 (de) Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
DE602005009255D1 (de) Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit
DE602005026964D1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE489382T1 (de) Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel
CL2008002353A1 (es) Compuestos derivados de 7h-indolo[2,1-a][2]benzazepina; composicion farmaceutica; y uso en el tratamiento de la hepatitis c.
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
DE502005006380D1 (de) Neue cycloalkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
ATE517105T1 (de) Neue imidazolon-derivate, wirkstoffpräparat daraus, pharmazeutische zusammensetzungen und ihre verwendung als hemmer von proteinkinasen, insbesondere cdc7
DE602006002887D1 (de) Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel